4
Changes in Ownership
Prelude Therapeutics Inc Filed Acc 0001562180-25-002392
CEO bought 97,500 shares at an average $0.71 ($69,564)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Vaddi Krishna CEO | 2025-03-12 | Purchase | +47,500 | $0.71 | $33,744 | 1,214,775 | D |
| Vaddi Krishna CEO | 2025-03-13 | Purchase | +50,000 | $0.72 | $35,820 | 1,264,775 | D |
| Open-market purchases · 97,500 sh · avg $0.71 · $69,564 | |||||||
Loading xslF345X05/primarydocument.xml…